LGVN - Longeveron reports positive results from Alzheimer's treatment trial
2023-12-20 12:21:53 ET
More on Longeveron
- Longeveron GAAP EPS of -$0.28 misses by $0.04, revenue of $0.2M misses by $0.07M
- Longeveron to implement ~$4M registered direct offering of shares
- Seeking Alpha’s Quant Rating on Longeveron
For further details see:
Longeveron reports positive results from Alzheimer's treatment trial